Deutsch English Français

Contact

EP2005177

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2005177

EP2005177 - A HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST METHOD [Right-click to bookmark this link]
Former [2008/52]	A HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM
	[2013/03]
Status	No opposition filed within time limit Status updated on 16.05.2014 Database last updated on 14.06.2024
Most recent event Tooltip	15.07.2016	Lapse of the patent in a contracting state New state(s): TR	published on 17.08.2016 [2016/33]
Applicant(s)	For all designated states Janssen R&D Ireland Eastgate Village Eastgate, Little Island, County Cork / IE
	[2013/28]
Former [2012/15]	For all designated states Janssen R&D Ireland Eastgate Village Eastgate Little Island Co Cork / IE
Former [2009/46]	For all designated states Tibotec Pharmaceuticals Eastgate Village Eastgate Little Island Co Cork / IE
Former [2008/52]	For all designated states Tibotec Pharmaceuticals Ltd. Eastgate Village Eastgate Little Island Co Cork / IE
Inventor(s)	01 / DAMS, Géry Karel Julia Nieuwe Erven 11 3583 Paal-Beringen / BE
	02 / VEREYCKEN, Inge August Van Putlei 213 2100 Deurne / BE
	03 / VAN ACKER, Koenraad Lodewijk August Uilenberg 30 9140 Temse / BE
	04 / GUSTIN, Emmanuel Marie Paul Ernest Bolk 94 2350 Vosselaar / BE
	05 / VERSCHUEREN, Wim Gaston De Wittestraat 5 2600 Berchem / BE
	06 / OHAGEN, Asa Catrine 128 Ingram Street, flat 4/2 G1 1EJ Glasgow / GB
	[2013/09]
Former [2009/07]	01 / DAMS, Géry Karel Julia Nieuwe Erven 11 B-3583 Paal-Beringen / BE
	02 / VEREYCKEN, Inge August Van Putlei 213 B-2100 Deurne / BE
	03 / VAN ACKER, Koenraad Lodewijk August Uilenberg 30 B-9140 Temse / BE
	04 / GUSTIN, Emmanuel Marie Paul Ernest Bolk 94 B-2350 Vosselaar / BE
	05 / VERSCHUEREN, Wim Gaston De Wittestraat 5 B-2600 Berchem / BE
	06 / OHAGEN, Asa Catrine 128 Ingram Street, flat 4/2 G1-1EJ Glasgow / GB
Former [2008/52]	01 / DAMS, Géry Karel Julia Nieuwe Erven 11 B-3583 Paal-Beringen / BE
	02 / VEREYCKEN, Inge August Van Putlei 213 B-2100 Deurne / BE
	03 / VAN ACKER, Koenraad Lodewijk August Uilenberg 30 B-9140 Temse / BE
	04 / GUSTIN, Emmanuel Marie Paul Ernest Bolk 94 B-2350 Vosselaar / BE
	05 / VERSCHUEREN, Wim Gaston De Wittestraat 5 B-2600 Berchem / BE
	06 / OHAGEN, Asa Catrine Koningin Astridlaan 54 B-2800 Mechelen / BE
Representative(s)	Daelemans, Frank F.R., et al J&J Patent Law Department Turnhoutseweg 30 2340 Beerse / BE
	[2010/34]
Former [2008/52]	Daelemans, Frank F.R. Tibotec-Virco Comm. VA J&J Patent Law Department Generaal De Wittelaan L 11B 3 2800 Mechelen / BE
Application number, filing date	07727885.1	06.04.2007
	[2008/52]
	WO2007EP53417
Priority number, date	EP20060112283	06.04.2006 Original published format: EP 06112283
	[2008/52]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2007113337
	Date:	11.10.2007
	Language:	EN
	[2007/41]
	Type:	A1 Application with search report
	No.:	EP2005177
	Date:	24.12.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.10.2007 takes the place of the publication of the European patent application.
	[2008/52]
	Type:	B1 Patent specification
	No.:	EP2005177
	Date:	10.07.2013
	Language:	EN
	[2013/28]
Search report(s)	International search report - published on:	EP	11.10.2007
Classification	IPC:	G01N33/542, G01N33/569	[2008/52]
	CPC:	G01N33/56988 (EP,US); G01N33/542 (EP,US)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2008/52]
Extension states	AL	06.11.2008
	BA	06.11.2008
	HR	06.11.2008
	MK	06.11.2008
	RS	06.11.2008
Title	German:	HOMOGENE ZEITAUFGELÖSTE TESTMETHODE AUF FLUORESZENZBASIS	[2013/03]
	English:	A HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST METHOD	[2013/03]
	French:	MÉTHODE DE TEST BASÉ SUR LA FLUORESCENCE EN TEMPS RÉSOLU EN MILIEU HOMOGÈNE	[2013/03]
	Former [2008/52]	HOMOGENES ZEITAUFGELÖSTES TESTSYSTEM AUF FLUORESZENZBASIS
	Former [2008/52]	A HOMOGENEOUS TIME RESOLVED FLUORESCENCE BASED TEST SYSTEM
	Former [2008/52]	SYSTÈME DE TEST BASÉ SUR LA FLUORESCENCE EN TEMPS RÉSOLU EN MILIEU HOMOGÈNE
Entry into regional phase	06.11.2008	National basic fee paid
	06.11.2008	Designation fee(s) paid
	06.11.2008	Examination fee paid
Examination procedure	06.11.2008	Examination requested [2008/52]
	29.06.2009	Despatch of a communication from the examining division (Time limit: M06)
	07.01.2010	Reply to a communication from the examining division
	17.11.2010	Despatch of a communication from the examining division (Time limit: M06)
	09.05.2011	Reply to a communication from the examining division
	07.12.2012	Date of oral proceedings
	07.01.2013	Minutes of oral proceedings despatched
	07.02.2013	Communication of intention to grant the patent
	29.05.2013	Fee for grant paid
	29.05.2013	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.06.2009
Opposition(s)	11.04.2014	No opposition filed within time limit [2014/25]
Fees paid	Renewal fee
	04.05.2009	Renewal fee patent year 03
	03.05.2010	Renewal fee patent year 04
	02.05.2011	Renewal fee patent year 05
	02.05.2012	Renewal fee patent year 06
	02.05.2013	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	HU	06.04.2007
	AT	10.07.2013
	BE	10.07.2013
	BG	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	MT	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	TR	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	IE	06.04.2014
	LU	06.04.2014
	[2016/33]
Former [2016/32]	HU	06.04.2007
	AT	10.07.2013
	BE	10.07.2013
	BG	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	MT	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	IE	06.04.2014
	LU	06.04.2014
Former [2016/25]	AT	10.07.2013
	BE	10.07.2013
	BG	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	MT	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	IE	06.04.2014
	LU	06.04.2014
Former [2016/16]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	MT	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	IE	06.04.2014
	LU	06.04.2014
Former [2015/21]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	IE	06.04.2014
	LU	06.04.2014
Former [2015/09]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	GB	06.04.2014
	LU	06.04.2014
Former [2015/01]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
	LU	06.04.2014
Former [2014/52]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	MC	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/24]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	IT	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/23]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	CZ	10.07.2013
	DK	10.07.2013
	EE	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	SK	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/22]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	DK	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	RO	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/21]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	DK	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/18]	AT	10.07.2013
	BE	10.07.2013
	CY	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/14]	CY	19.06.2013
	AT	10.07.2013
	BE	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	NL	10.07.2013
	PL	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/12]	CY	19.06.2013
	AT	10.07.2013
	BE	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	LV	10.07.2013
	PL	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	GR	11.10.2013
	ES	21.10.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/11]	CY	19.06.2013
	AT	10.07.2013
	BE	10.07.2013
	FI	10.07.2013
	LT	10.07.2013
	PL	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/10]	CY	19.06.2013
	AT	10.07.2013
	BE	10.07.2013
	LT	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	IS	10.11.2013
	PT	11.11.2013
Former [2014/09]	AT	10.07.2013
	BE	10.07.2013
	LT	10.07.2013
	SE	10.07.2013
	SI	10.07.2013
	PT	11.11.2013
Former [2014/08]	LT	10.07.2013
	SI	10.07.2013
	PT	11.11.2013
Former [2013/49]	SI	10.07.2013
Cited in	International search	[XY]US2002077284 (ECKERT DEBRA M [US], et al) [X] 1-9,13-16,20 the whole document, especially paragraphs 0005, 0121-0123, 0142 figure 4 [Y] 10-12,17-19;
		[XY]WO03027255 (TIBOTEC PHARM LTD [IE], et al) [X] 1-9,13-16,20 Abstract, claims, page 10, line 29 - page 11, line 2, page 14, line 25 - page 15, line 16 [Y] 10-12,17-19;
		[XA]WO2004076640 (AMBION INC [US], et al) [X] 21 * table 2 * [A] 22;
		[XA]US2005014169 (LATHAM GARY J [US], et al) [X] 21 * tables 2,15 * [A] 22;
		[A]WO2005118886 (MERCK & CO INC [US], et al) [A] 1-22* the whole document *;
		[Y] - CUMMINGS R T ET AL, "Use of a phosphotyrosine-antibody pair as a general detection method in homogeneous time-resolved fluorescence: application to human immunodeficiency viral protease", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS, SAN DIEGO, CA, US, (19990410), vol. 269, ISSN 0003-2697, pages 79 - 93, XP002975213 [Y] 10,11,17,18 * page 80, column L, line 3 - line 18 * DOI: http://dx.doi.org/10.1006/abio.1999.4021
		[Y] - SELVIN P R ET AL, "LUMINESCENCE ENERGY TRANSFER USING A TERBIUM CHELATE: IMPROVEMENTS ON FLUORESCENCE ENERGY TRANSFER", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (199410), vol. 91, ISSN 0027-8424, pages 10024 - 10028, XP001018013 [Y] 10,12,17,19 * abstract * DOI: http://dx.doi.org/10.1073/pnas.91.21.10024
		[XA] - KAO R Y T ET AL, "A SMALL-MOLECULE INHIBITOR OF THE RIBONUCLEOLYTIC ACTIVITY OF HUMAN ANGIOGENIN THAT POSSESSES ANTITUMOR ACTIVITY", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (20020723), vol. 99, no. 15, ISSN 0027-8424, pages 10066 - 10071, XP002271723 [X] 21 * figure 2 * [A] 22 DOI: http://dx.doi.org/10.1073/pnas.152342999
		[XA] - JENKINS J L ET AL, "VIRTUAL SCREENING TO ENRICH HIT LISTS FROM HIGH-THROUGHPUT SCREENING: A CASE STUDY ON SMALL-MOLECULE INHIBITORS OF ANGIOGENIN", PROTEINS: STRUCTURE, FUNCTION AND GENETICS, ALAN R. LISS, US, (20030101), vol. 50, no. 1, ISSN 0887-3585, pages 81 - 93, XP008062395 [X] 21 * figure 4 * [A] 22 DOI: http://dx.doi.org/10.1002/prot.10270
		[A] - JIANG S ET AL, "A SCREENING ASSAY FOR ANTIVIRAL COMPOUNDS TARGETED TO THE HIV-1 GP41 CORE STRUCTURE USING A CONFORMATION-SPECIFIC MONOCLONAL ANTIBODY", JOURNAL OF VIROLOGICAL METHODS, AMSTERDAM, NL, (1999), vol. 80, ISSN 0166-0934, pages 85 - 96, XP001013466 [A] 1-22 * the whole document * DOI: http://dx.doi.org/10.1016/S0166-0934(99)00041-5

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p